Dimensional Fund Advisors
IMRX icon

Dimensional Fund Advisors’s Immuneering IMRX Stock Holding History

Dimensional Fund Advisors’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.6K Hold
19,562
– – ﹤0.01% 3141
2026
Q1 		$103K Hold
19,562
– – ﹤0.01% 3116
2025
Q4 		$129K Hold
19,562
– – ﹤0.01% 3125
2025
Q3 		$137K Buy
19,562
+6,196
+46% +$32.2K ﹤0.01% 3161
2025
Q2 		$45.2K Hold
13,366
– – ﹤0.01% 3240
2025
Q1 		$20.4K Hold
13,366
– – ﹤0.01% 3304
2024
Q4 		$29.4K Hold
13,366
– – ﹤0.01% 3318
2024
Q3 		$33.4K Hold
13,366
– – ﹤0.01% 3321
2024
Q2 		$17.2K Sell
13,366
-17,983
-57% -$29.6K ﹤0.01% 3357
2024
Q1 		$90.6K Buy
31,349
+14,665
+88% +$82.2K ﹤0.01% 3269
2023
Q4 		$123K Hold
16,684
– – ﹤0.01% 3259
2023
Q3 		$128K Buy
+16,684
New +$153K ﹤0.01% 3287

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Dimensional Fund Advisors's IMRX Position: Q2 2026 in Review

Dimensional Fund Advisors held its Immuneering (IMRX) position steady in Q2 2026 at 19,562 shares worth $97.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3141.

Dimensional Fund Advisors first reported a position in IMRX in Q3 2023 and has held it in 12 quarters since. The position peaked at $137K in Q3 2025. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Dimensional Fund Advisors held 19,562 shares of Immuneering worth $97.6K as of Q2 2026.
  • Dimensional Fund Advisors left its Immuneering share count unchanged in Q2 2026.
  • Immuneering made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3141 holding.
  • Dimensional Fund Advisors first reported a position in Immuneering in Q3 2023 and has held it in 12 quarters since.
  • Dimensional Fund Advisors's Immuneering position peaked at $137K in Q3 2025.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.